Pacira BioSciences, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Pacira BioSciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2024.
  • Pacira BioSciences, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $671K.
  • Pacira BioSciences, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $10M.
  • Pacira BioSciences, Inc. annual Nonoperating Income (Expense) for 2023 was -$26M, a 44.4% increase from 2022.
  • Pacira BioSciences, Inc. annual Nonoperating Income (Expense) for 2022 was -$46.7M, a 39.4% decline from 2021.
  • Pacira BioSciences, Inc. annual Nonoperating Income (Expense) for 2021 was -$33.5M, a 27.6% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $10M $671K +$1.79M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $8.2M $8.34M +$10.4M Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 -$2.16M $428K +$23.8M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$26M $552K +$8.73M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$34.7M -$1.12M +$18.1M +94.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$52.8M -$2.02M +$7.21M +78.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 -$60M -$23.4M -$13.3M -132% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$46.7M -$8.18M +$2.24M +21.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$49M -$19.2M -$12M -167% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$36.9M -$9.23M -$33K -0.36% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$36.9M -$10.1M -$3.39M -50.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 -$33.5M -$10.4M -$4.32M -70.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$29.2M -$7.2M +$4.27M +37.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$33.5M -$9.2M -$9.03M -5507% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$24.4M -$6.71M +$1.82M +21.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$26.3M -$6.09M -$836K -15.9% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$25.4M -$11.5M -$3.24M -39.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$22.2M -$164K +$3.98M +96% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 -$26.2M -$8.54M -$4.94M -137% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 -$21.2M -$5.25M -$1.31M -33.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 -$19.9M -$8.23M -$3.48M -73.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 -$16.4M -$4.15M -$206K -5.23% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$16.2M -$3.6M +$111K +2.99% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$16.3M -$3.94M -$105K -2.74% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$16.2M -$4.75M -$770K -19.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$15.5M -$3.94M -$9K -0.23% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$15.5M -$3.71M +$2.08M +35.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 -$17.5M -$3.84M -$2.3M -150% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 -$15.2M -$3.98M -$2.72M -215% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 -$12.5M -$3.93M -$2.48M -170% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 -$10M -$5.79M -$4.22M -269% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 -$5.82M -$1.53M +$260K +14.5% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$6.08M -$1.26M +$479K +27.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$6.56M -$1.46M +$315K +17.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 -$6.87M -$1.57M +$461K +22.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 -$7.34M -$1.79M +$6.59M +78.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 -$13.9M -$1.74M +$277K +13.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 -$14.2M -$1.77M +$424K +19.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$14.6M -$2.03M +$190K +8.56% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 -$14.8M -$8.38M -$6.24M -292% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 -$8.57M -$2.02M -$49K -2.49% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
Q2 2014 -$8.52M -$2.2M -$174K -8.61% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 -$8.35M -$2.22M +$2.72M +55% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-30
Q4 2013 -$11.1M -$2.14M -$1.62M -313% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-25
Q3 2013 -$9.44M -$1.97M -$1.93M -4951% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-30
Q2 2013 -$7.51M -$2.02M -$351K -21% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 -$7.16M -$4.94M -$4.18M -552% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 -$2.98M -$517K +$50K +8.82% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 -$3.03M -$39K +$736K +95% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-31
Q2 2012 -$3.77M -$1.67M -$1.44M -620% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 -$2.33M -$757K +$1.9M +71.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 -$4.23M -$567K Oct 1, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 -$775K +$674K +46.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 -$232K +$953K +80.4% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$2.65M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 -$1.45M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 -$1.19M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.